Jaguar Health (JAGX) Debt to Equity (2016 - 2025)
Jaguar Health (JAGX) has disclosed Debt to Equity for 11 consecutive years, with $1.75 as the latest value for Q3 2025.
- On a quarterly basis, Debt to Equity rose 6.09% to $1.75 in Q3 2025 year-over-year; TTM through Sep 2025 was $1.75, a 6.09% increase, with the full-year FY2024 number at $3.62, down 42.82% from a year prior.
- Debt to Equity was $1.75 for Q3 2025 at Jaguar Health, up from $1.56 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $22.2 in Q1 2025 to a low of -$13.06 in Q4 2022.
- A 5-year average of $4.01 and a median of $2.11 in 2021 define the central range for Debt to Equity.
- Peak YoY movement for Debt to Equity: plummeted 718.5% in 2022, then surged 1108.27% in 2025.
- Jaguar Health's Debt to Equity stood at $2.11 in 2021, then tumbled by 718.5% to -$13.06 in 2022, then soared by 148.47% to $6.33 in 2023, then crashed by 42.82% to $3.62 in 2024, then crashed by 51.52% to $1.75 in 2025.
- Per Business Quant, the three most recent readings for JAGX's Debt to Equity are $1.75 (Q3 2025), $1.56 (Q2 2025), and $22.2 (Q1 2025).